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There has been a growing interest in vascular impairment associated with Alzheimer’s dis-
ease (AD). This interest was stimulated by the findings of higher incidence of vascular risk
factors in AD. Signs of vascular impairment were investigated notably in the field of imag-
ing methods. Our aim was to explore ultrasonographic studies of extra- and intracranial
vessels in patients with AD and mild cognitive impairment (MCI) and define implications
for diagnosis, treatment, and prevention of the disease. The most frequently studied para-
meters with extracranial ultrasound are intima-media thickness in common carotid artery,
carotid atherosclerosis, and total cerebral blood flow. The transcranial ultrasound concen-
trates mostly on flow velocities, pulsatility indices, cerebrovascular reserve capacity, and
cerebral microembolization. Studies suggest that there is morphological and functional
impairment of cerebral circulation in AD compared to healthy subjects. Ultrasound as a
non-invasive method could be potentially useful in identifying individuals in a higher risk of
progression of cognitive decline.
Keywords: Alzheimer’s disease, carotid ultrasound, cerebrovascular reserve capacity, neurosonology, transcranial
ultrasound
VASCULAR CHANGES AND ALZHEIMER’S DISEASE
In an effort to reveal an etiopathogenic mechanism responsible for
Alzheimer’s disease (AD) many hypotheses have been postulated.
Recent failures of candidate disease-modifying medications have
led to many alternative theories of AD pathophysiology. Multiple
studies suggest that the risk of AD is apart from other factors
associated with midlife hypertension, diabetes mellitus, hyper-
cholesterolemia, and other vascular risk factors (Breteler, 2000;
Casserly and Topol, 2004; Gorelick, 2004; Shah et al., 2012). This
association has led to a hypothesis that the vascular risk factors
could play an important role in the genesis or in the progression
of the disease, but even after years of research the role of vascular
risk factors in AD remains a subject of discussion. Two principal
theories were postulated. First, an impaired cerebral circulation
from any cause leads to neurodegeneration (de la Torre, 2010).
Second, vascular impairment from any cause (e.g., atherosclerosis)
accelerates the rate of progression of neurodegeneration (Kalaria,
2002). The second theory is generally more accepted.
Various imaging methods were used to explore the signs of vas-
cular impairment in AD. White matter lesions in people above
65 years are associated with typical vascular risk factors and cog-
nitive decline (Breteler et al., 1994; DeCarli et al., 2001; Wu et al.,
2002). Higher extent of white matter lesions in MCI patients is
associated with higher risk of progression of MCI to demen-
tia of any kind (Wolf et al., 2000). In MCI patients, there is a
regional hypoperfusion on SPECT examination in hippocampus,
amygdala, and prefrontal cortex (Johnson et al., 1998), and in
AD patients the perfusion is decreased in whole temporoparietal
region and correlates with the disease severity (DeKosky et al.,
1990) [AD patient with varying disease severity were divided into
four groups according to mini-mental state examination (MMSE):
>24; 22–24; 15–21;<15].
The objective of this review was to explore extracranial and
transcranial ultrasound projects in AD patients. We tried to
describe the pattern of functional or structural cerebrovascular
impairment in AD as characterized by ultrasonography, and to
summarize ultrasound parameters of cerebral circulation in AD
vs. healthy control subjects or in AD patients longitudinally. We
have discussed to what extent neurosonological examination could
contribute to diagnosis, prevention, or treatment of AD. We have
also discussed whether there is a special pattern of circulation
impairment, namely: Is AD associated with large vessel or, rather,
small vessel disease? Are there predominant changes in a specific
region of the brain? Is the incidence of microembolization higher
in AD, or is there a correlation of any parameter with disease
progression?
EXTRACRANIAL ULTRASOUND IN AD
Main parameters that can be assessed by extracranial ultrasound
are parameters of arterial wall [carotid intima-media thickness
(IMT) and atherosclerotic plaques] and cerebral perfusion [total
cerebral blood flow (CBF)].
IMT AND CAROTID ATHEROSCLEROSIS
Carotid IMT is defined as a distance between media–adventitia
interface and intima–lumen interface measured on the common
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carotid artery, 1–2 cm proximally from bifurcation or, less fre-
quently, on the internal carotid artery using automated analyzers
implemented in most of the recent ultrasound devices. IMT is
generally regarded as a marker of atherosclerosis and is a good
predictor of future vascular events (Lorenz et al., 2007). To ensure
the accuracy of IMT measurements, it is necessary to meet the
technical, methodological, and operator related criteria (Gonzalez
et al., 2008; Stein et al., 2009; Dogan et al., 2010; Society of Ath-
erosclerosis Imaging and Prevention Developed in collaboration
with the International Atherosclerosis Society, 2011; Touboul et al.,
2012). Thanks to these criteria, the validity and reproducibility of
IMT measurement are sufficient and IMT measurement is widely
used in clinical practice as well as in the research, and is imple-
mented in several guidelines for cardiovascular risk assessment
(National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood Choles-
terol in Adults (Adult Treatment Panel III), 2002; de la Sierra et al.,
2009; Stein et al., 2009; Greenland et al., 2010; Society of Athero-
sclerosis Imaging and Prevention Developed in collaboration with
the International Atherosclerosis Society, 2011).
Atherosclerotic plaque is defined as a focal structure at a ves-
sel wall protruding into the arterial lumen showing a thickness of
more than 1.5 mm from the adventitia–media interface (Touboul
et al., 2012). Number, proportions, and location of plaques as
well as the presence of carotid stenosis caused by plaques need to
be considered in the assessment of carotid atherosclerosis sever-
ity. The severity of carotid stenosis is quantified according to
the flow velocities in the stenosis, residual lumen, and internal
carotid artery/common carotid artery flow velocities ratio (Grant
et al., 2003). There was a great emphasis on the standardization of
the stenosis assessment for the reason of legitimate indication of
carotid endarterectomy. The validity and reproducibility of the
examination are sufficient for clinical as well as research pur-
poses as long as the technical and personnel conditions are fulfilled
(Mohler et al., 2012).
Epidemiological studies have evidenced that AD and VD share
common risk factors, which include vascular risk factors such
as hypertension, smoking, diabetes mellitus, and hypercholes-
terolemia (Casserly and Topol, 2004; Gorelick, 2004). These risk
factors are also the principal risk factors of atherosclerosis (Greco
et al., 2013); considering this, we would expect higher prevalence
of large vessel disease in AD than in general population. The results
of two large substudies of the prospective cohort of population-
based Rotterdam study are in accordance with this hypothesis
(Hofman et al., 1997; van Oijen et al., 2007). Both of these substud-
ies were focused on IMT and the degree of carotid (and generally
peripheral) atherosclerosis in demented, both AD and vascular
dementia (VD), and non-demented subjects. The cross-sectional
analysis indicated that the more prominent carotid atherosclero-
sis the higher probability of dementia. This finding applies for
VD, where the association is strong because the atherosclerosis is
the principle of the dementia itself, as well as for AD. The lon-
gitudinal analysis included measurements at baseline and after
7–9 years and showed that the increased IMT is in the short-term
period associated with an increased risk of developing AD. Due
to the increased mortality in population with increased IMT, the
effect was attenuated in the long-term follow-up (van Oijen et al.,
2007). No difference in carotid atherosclerosis is found between
AD and high vascular risk patients with VD. This implies that a
certain level of impairment is present in both. Concerning the
IMT, considered the incipient form of atherosclerosis, also no dif-
ference between AD and VD patients was found (Morovic et al.,
2009).
In this context, the studies of cognitive decline in asympto-
matic carotid stenosis are very interesting. High-degree carotid
stenosis (70–99%) or carotid occlusion can be associated with
cognitive decline in patients without otherwise clinically evident
cerebrovascular disease, making the term “asymptomatic” stenosis
somewhat arguable (Johnston et al., 2004; Balucani et al., 2012;
Chang et al., 2013). The severity of impairment depends on the
quality of collateral blood supply; the character of cognitive decline
is influenced by the side of stenosis given by the distinctive func-
tions of cerebral hemispheres. In left-sided stenosis, the verbal
memory impairment is more frequent, and in right-sided steno-
sis there is more prominent visuospatial deficit (Balucani et al.,
2012; Zavoreo et al., 2013). Two possible processes are considered
in the pathophysiology – silent microembolism or hypoperfusion
(Sztriha et al., 2009; Demarin et al., 2012). The carotid endarterec-
tomy or carotid stenting and following reperfusion can improve
the mental functions; on the other hand, during both procedures,
the microembolism and hypoperfusion can occur as well and cause
worsening of the cognitive decline.
Although the IMT in AD is generally increased as compared
to healthy population, it does not correlate with cognitive per-
formance in cross-sectional trials (Modrego et al., 2008). In lon-
gitudinal studies, IMT and atherosclerosis severity in AD patients
correlate with the progression of cognitive impairment (Silvestrini
et al., 2009). The progression is faster in AD patients with higher
degree of carotid stenosis than in AD patients without stenosis
(Silvestrini et al., 2011). Abnormal values of IMT also significantly
increase the risk of conversion from amnestic MCI to AD (Viticchi
et al., 2012). In a longitudinal study involving a 6-month galant-
amine treatment of AD, the patients with lower values of IMT at
baseline had better response to treatment (Modrego et al., 2009),
which suggests that AD patients with lower cerebrovascular burden
have slower progression of disease. Details of ultrasound projects
focused on IMT and carotid atherosclerosis in AD are listed in
Table 1.
TOTAL CBF
Total CBF can be assessed by ultrasonography when measuring
flow velocities in carotid and vertebral arteries and multiplying
the result by the cross-sectional area of the vessels (average of sys-
tolic and diastolic areas). The results gained by this method are
comparable to nitrous oxide and SPECT measurements giving the
average CBF in a healthy subject of approximately 54 ml/100 g/min
(Schoning et al., 1994). Insignificant errors in the measurement of
flow velocities and vessel diameter can give significant errors in the
final blood flow, up to 10%, but the accuracy and reproducibility
of measurement are acceptable when repeated measurements are
done and the average is calculated (Gill, 1985; Schoning and Scheel,
1996).
Total CBF reduces with age (Dorfler et al., 2000) and brain
parenchymal volume (van Es et al., 2010). According to ultrasound
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Table 1 | IMT and carotid atherosclerosis.
Reference Aim of study Type of study n MCI n AD n VD n Controls Parameters Outcome
Hofman et al.
(1997)
Frequency of
dementia and its
subtypes in relation to
atherosclerosis and
apo-E
Cross-
sectional
207 50 1698 IMT and
atherosclerotic
plaques in CCA and
ICA, ankle and
brachial systolic
pressure
The risk of dementia of any
type increases with the
severity of atherosclerosis
Modrego et al.
(2008)
Correlation of
cognitive decline,
WML and IMT in AD
Cross-
sectional
51 Neuropsychological
tests, WML on MRI,
IMT in CCA
No correlation of clinical
scales with WML or IMT
Modrego et al.
(2009)
Association of IMT
and response to
ACHEI treatment in
AD
Longitudinal 50 IMT in CCA and
neuropsychological
tests at time 0 and
after 6 months while
on galantamine
treatment
Better response to
galantamine treatment in
lower IMT
Morovic et al.
(2009)
Difference in IMT, beta
stiffness index and
CCA diameter
between AD and VD
Cross-
sectional
16 22 IMT, beta stiffness
index and lumen
diameter in CCA
No significant difference in
any parameter between
AD and VD
Purandare
et al. (2005)
Frequency of cerebral
emboli, v-a circulation
shunts and carotid
artery disease in
dementia and controls
Cross-
sectional
24 17 16 Spontaneus cerebral
emboli in MCAs,
bubbles in MCAs,
PSV in ICA
More cerebral microemboli
in VD than controls, in AD
not significant, no
difference in v-a shunt or
carotid stenosis between
dementia and controls
Silvestrini et al.
(2009)
Correlation of carotid
atherosclerosis
progression and
cognitive impairment
in AD
Longitudinal 66 Carotid plaques, flow
velocities, PI and
IMT in CCA in time 0
and 12 month, while
treated with
galantamine
Significant correlation of
cognitive decline with
baseline IMT, IMT change,
PI change,
antihypertensive drugs
Silvestrini et al.
(2011)
Association of ICA
stenosis with
cognitive decline
progression in AD
Longitudinal 411 ICA plaques and flow
velocities at baseline
and in 12 months
Faster progression of
cognitive decline in severe
stenosis
van Oijen et al.
(2007)
Association of
atherosclerosis with
dementia subtypes
Longitudinal 476 78 IMT and plaques in
CCA and ICA
Higher IMT associated
with greater risk of AD
Viticchi et al.
(2012)
Association of carotid
atherosclerosis and
cerebrovascular
reactivity with the risk
of conversion from
MCI to AD
Longitudinal 117 21 IMT and plaques in
CCA, BHI in MCAs
Association of higher IMT
and lower BHI with faster
progression from MCI to
dementia
ACHEI, acetylcholine esterase inhibitor; AD, Alzheimer’s disease; BHI, breath holding index; CCA, common carotid artery; ICA, internal carotid artery; IMT, intima-
media thickness; MCA, middle cerebral artery; MCI, mild cognitive impairment; MRI, magnetic resonance imaging; PI, pulsatility index; PSV, peak systolic velocity;
v-a, venous-to-arterial; VD, vascular dementia; WML, white matter lesions.
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studies, the total CBF is significantly lower in both AD and VD than
in healthy controls of the same age (Maalikjy Akkawi et al., 2003;
Schreiber et al., 2005; Doepp et al., 2006). This corresponds with
changes described for an ICA flow curve in AD, where both systolic
and diastolic velocities are lower compared to healthy individuals
(Gusti et al., 2004). The association of total CBF with percentage of
brain atrophy is weak (van Es et al., 2010). In an ultrasound study
of three groups of patients with documented cerebral atrophy (AD,
VD, and cognitively normal subjects), the total CBF was signifi-
cantly lower in patients with dementia than in those without a
cognitive impairment. There was no significant difference between
two types of dementia (Albayrak et al., 2006). Details of ultrasound
projects focused on total CBF in AD are listed in Table 2.
TRANSCRANIAL ULTRASOUND IN AD
FLOW VELOCITIES, CEREBROVASCULAR RESISTANCE, AND
CEREBROVASCULAR RESERVE CAPACITY
The CBF curve in a transcranial ultrasound examination is char-
acterized by two main flow velocities – peak systolic velocity and
end diastolic velocity. These velocities can be measured in all major
intracranial vessels – anterior, middle, and posterior cerebral arter-
ies, vertebral arteries; and basilar artery. The mean flow velocity
and indices describing the resistance of intracranial vessels can be
derived from the flow curve. The reproducibility of flow veloci-
ties measurement is good when done by an experienced examiner
(McMahon et al., 2007).
Many studies have found significantly lower flow velocities in
AD compared to controls (Caamano et al., 1993; Roher et al.,
2006, 2011; Sun et al., 2007; Vicenzini et al., 2007; Claassen et al.,
2009; Stefani et al., 2009; Gucuyener et al., 2010). The most often
studied vessel was the middle cerebral artery (MCA) while other
major intracranial arteries were studied less frequently. The most
often decreased velocity in MCA in AD patients compared to
healthy controls was the mean flow velocity (Roher et al., 2006,
2011; Vicenzini et al., 2007; Claassen et al., 2009; Stefani et al.,
2009), although not all results support these findings (Ries et al.,
1993). Decreases in peak systolic and end diastolic velocities var-
ied in different arteries (Caamano et al., 1993; Sun et al., 2007;
Gucuyener et al., 2010). According to a large longitudinal study
(Ruitenberg et al., 2005), subjects with higher velocities in MCA
Table 2 |Total cerebral blood flow.
Reference Aim of study Type of study n MCI n AD n VD n Controls Parameters Outcome
Albayrak
et al. (2006)
Comparison of cerebral
blood flow in demented
(AD, VD) and cognitively
normal subjects, both
with brain atrophy
Cross-sectional 9 9 10 Flow velocities and
cross-sectional area
of the vessel in ICAs
and VAs
Total, anterior and right
CBF lower in dementia, no
difference between two
types of dementia
Doepp et al.
(2006)
Possible differentiation of
AD and VD by various
extra- and intracranial
ultrasound parameters
Cross-sectional 20 20 12 Flow velocities and
PI in MCAs, flow
velocities and
cross-sectional area
in ICAs and VAs,
cerebral circulation
time, global cerebral
blood volume
No significant difference in
trans- and extracranial
ultrasound between AD
and VD
Gusti et al.
(2004)
Comparison of carotid
flow velocities and flow
curve in AD and controls
Cross-sectional 18 40 Flow velocities in
carotid arteries
Lower cerebral vascular
filling in AD
Maalikjy
Akkawi et al.
(2003)
Possibility of CBF volume
assessment by TCD,
difference between AD
and controls, correlation
with cognitive decline
Cross-sectional 50 50 Flow velocities and
vessel diameter in
ICA and VA,
calculation of
cerebral blood flow
Decrease in CBF volume in
AD compared to controls,
positive correlation
between dementia
severity and CBF
Schreiber
et al. (2005)
CBF, cerebral circulation
time and cerebral blood
volume in AD, VD and
controls
Cross-sectional 20 20 12 Flow velocity and
cross-sectional area
of ICA and VA, time
of contrast agent
transfer from
ICA to IJV
Difference in CBF and
transit time between
dementia and controls, no
difference in CBF volume
or between AD and VD
AD, Alzheimer’s disease; CBF, cerebral blood flow; ICA, internal carotid artery; IJV, internal jugular vein; MCA, middle cerebral artery; MCI, mild cognitive impairment;
PI, pulsatility index; TCD, transcranial Doppler; VA, vertebral artery; VD, vascular dementia.
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were less likely to develop AD. The question is – why the decrease
should be most prominent in the MCA. We speculate this could
be a consequence of pathological changes in AD, where tem-
poral and parietal lobes supplied by MCA are most affected.
In this context, a comparison of healthy subjects and patients
with MCI would be interesting, but the results are ambiguous
(Roher et al., 2011). No significant difference in flow velocities
was found between AD and VD, neither there is a significant side
asymmetry.
Unlike SPECT, the transcranial Doppler measures only flow
velocities and not absolute blood flow, and the assessment of
flow velocities is not helpful in an individual patient due to the
wide range of normal values of flow velocities. The methods for
assessment of regional cerebral perfusion or metabolism (SPECT,
PET) have high sensitivity and specificity in distinguishing AD
vs. normal controls (depending on the stage of the disease and
method employed) based on characteristic perfusion or metab-
olism reduction in temporoparietal association cortex: SPECT
can reach sensitivity of 65–96% and specificity of 80–87%, PET
can reach even sensitivity of 93–94% and specificity of 63–73%
(Wollman and Prohovnik, 2003; Matsuda, 2007). These two meth-
ods can be used to make the clinical diagnosis of AD more accurate
in some unclear cases.
A parameter describing autoregulation of cerebral perfusion is
cerebrovascular reserve capacity, which reflects the capability of
brain microvasculature to regulate cerebral perfusion in a reaction
to various stimuli, thanks to constriction or dilatation. The most
often used stimulus is a change of the arterial CO2 level that can
be induced using breath holding, CO2 inhalation, or intravenous
acetazolamide injection. Other less often used stimuli include
hand movement, cognitive exercise, or blood pressure challenge
(i.e., physical exercise). The cerebrovascular reserve capacity is
expressed as the ratio of mean flow velocity in basal conditions
and mean flow velocity in the conditions of a higher CO2 level. In
normal brain, there is an increase in flow velocities. When breath
holding is the stimulus, the ratio can be multiplied by the duration
of breath holding and expressed as breath holding index (BHI).
Cerebrovascular reserve capacity decreases with age (Peisker et al.,
2010).
The cerebrovascular reserve capacity is in clinical practice rou-
tinely tested before revascularization procedures in carotid stenosis
or occlusion. The established methods for cerebrovascular reserve
capacity assessment are scintigraphic techniques such as SPECT
and PET with the use of various radioactive tracer compounds,
all of them evaluating the cerebral perfusion in basal conditions
and after vasodilatory stimulus (acetazolamide injection or CO2
inhalation). In comparison with these direct techniques, the tran-
scranial Doppler examination is an indirect assessment based on
the relative increase in flow velocities after vasodilatory stimu-
lus (usually acetazolamide injection, CO2 inhalation or breath
holding). All three transcranial Doppler methods correlate very
well to 133Xe SPECT (Bishop et al., 1986; Dahl et al., 1992;
Muller et al., 1995) with the breath-holding method being the less
accurate but sufficient for first screening examination (Markus
and Harrison, 1992; Muller et al., 1995). Compared to scinti-
graphic techniques the ultrasound examination is non-invasive
and inexpensive.
Concerning the cerebrovascular reserve capacity measured by
transcranial Doppler in the MCA in AD patients, the results
are more consistent than those for solely flow velocities. In AD
patients, the reactivity to different stimuli in the MCA is signifi-
cantly lower than in healthy controls (Provinciali et al., 1990; Bar
et al., 2007; Lee et al., 2007; Vicenzini et al., 2007; Stefani et al.,
2009). Only some studies with fewer subjects do not fully sup-
port these findings (Matteis et al., 1998; Claassen et al., 2009). In
one of these studies, the result could be influenced by the selec-
tion of very mild AD cases (MMSE 25) (Claassen et al., 2009).
In another study, it is not sufficiently described how the cogni-
tive impairment was ruled out in control subjects (Matteis et al.,
1998). One study proved a better cerebrovascular reserve capacity
in AD than VD, but the result was not statistically significant (Lik-
itjaroen et al., 2009). Healthy subjects with higher cerebrovascular
reserve capacity are less likely to develop a cognitive decline (AD
or VD) (Ruitenberg et al., 2005). Although the impairment of
cerebrovascular reserve capacity is more serious in VD, it seems
that the microvasculature is altered in both main types of dementia
(Bar et al., 2007; Vicenzini et al., 2007).
On the other hand, the hypercapnia challenge in SPECT and
PET studies give ambiguous results without convincing evidence
of decreased cerebrovascular reserve capacity in AD (Yamaguchi
et al., 1980; Bonte et al., 1989; Kuwabara et al., 1992; Stoppe et al.,
1995; Knapp et al., 1996; Jagust et al., 1997; Oishi et al., 1999; Pavics
et al., 1999). However, it must be taken into account that in earlier
publications, the diagnostic criteria for AD may differ from nowa-
days criteria and older devices may not give very accurate results
(Glodzik et al., 2013).
Again the comparison with asymptomatic carotid stenosis
or occlusion is interesting. In cases of high degree stenosis or
occlusion with insufficient collateral blood supply, the chronic
hypoperfusion exhausts the cerebrovascular reserve. This can be
observed in different examination methods (Oka et al., 2013)
including transcranial Doppler ultrasound examination using
BHI (Balestrini et al., 2013; Zavoreo et al., 2013). The decrease
of cerebrovascular reserve capacity correlates with the cognitive
decline (Zavoreo et al., 2013).
The cerebrovascular reserve capacity of posterior cerebral
artery in reaction to a visual stimulus was often tested. The
function of occipital lobe should be preserved until late stages of
AD. The results of such projects were ambiguous (Asil and Uzuner,
2005; Rosengarten et al., 2006, 2007; Gucuyener et al., 2010) and,
thus, not differentiating AD from VD.
The reason for the decreased cerebrovascular reserve capacity is
not entirely clear. InVD, the cause is probably a small vessel disease.
In AD, amyloid deposits represent the likely culprit – in cerebral
amyloid angiopathy, the cerebrovascular reserve capacity is also
compromised (Menendez-Gonzalez et al., 2011). Another hypoth-
esis suggests the role of insufficient acetylcholine production
necessary for vasodilatation. Therapeutic tests with acetylcholine
inhibitors (galantamine or donepezil) demonstrated an increase
in flow velocities and improvement of vessel reactivity in both VD
and AD (Rosengarten et al., 2006; Bar et al., 2007; Ghorbani et al.,
2010). In longitudinal follow-up studies, the BHI significantly cor-
related with neuropsychological tests – MMSE and Alzheimer’s
Disease Assessment Scale-cognitive subscale (ADAS-Cog) in AD
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Table 3 | Flow velocities, cerebrovascular resistance, and cerebrovascular reserve capacity.
Reference Aim of study Type of study n MCI n AD n VD N Controls Parameters Outcome
Asil and
Uzuner (2005)
Assessment of
CVRC in the
occipital lobe in
AD
Cross-sectional 15 12 9 Flow velocities in
PCAs during eyes
opened and eyes
closed
No significant difference
neither in flow velocities at
rest nor at stimuli in three
groups; decreased reactivity
in VD at stimulus
Bar et al.
(2007)
CVRC in AD
compared to VD
and healthy
controls,
reactivity after
ACHEI treatment
Cross-sectional
Longitudinal
17 17 20 Flow velocities in
MCA at rest and
after CO2 inhalation
in AD and VD
repeated after
5 weeks of
galantamine
treatment
CVRC in MCA decreased in
AD and VD in comparison to
healthy controls, better CVRC
after galantamine treatment
on both AD and VD
Caamano et al.
(1993)
Comparison of
flow velocities in
MCA and BA in
AD, VD and
controls
Cross-sectional 12 12 12 Flow velocities in
right and left MCA
and BA
Decreased values in
demented patients
Claassen et al.
(2009)
Assessment of
cerebral
hemodynamics
impairment in
early stage AD
Cross-sectional 9 8 Flow velocities in
MCA, blood
pressure,
cerebrovascular
resistance index
Significantly reduced flow
velocities and increased
resistance in AD
Ghorbani et al.
(2010)
Assessment of
the effect of
Donepezil on
cerebral blood
flow velocity in
AD patients
Longitudinal 11 Flow velocities in
PCA and MCA at
baseline, after
4 weeks of donepezil
5 mg and after
another 4 weeks of
donepezil 10 mg
Increase in PSV and MFV in
MCA, and MFV and EDV in
PCA after 10 mg treatment
Gucuyener
et al. (2010)
CVRC in PCAs in
AD compared to
depressive
pseudo-dementia
Cross-sectional 11 13 10 Flow velocities in
both PCAs
simultaneously; in
steady state and
after a visual
stimulus
Lower flow velocities at rest
and after stimulus in both AD
and depressive
pseudodementia then
controls. CVRC impaired in
AD, not in depressive
pseudodementia
Lee et al.
(2007)
Assessment of
CVRC in AD
Cross-sectional 17 17 Flow velocities and
PI in MCA bilaterally
in normal conditions
and after 5 min of
rebreathing
No difference in baseline MFV
and PI between subjects and
controls, CVRC significantly
decreased on both sides in
AD
Likitjaroen
et al. (2009)
Comparison of
CVRC in AD and
VD
Cross-sectional 9 9 Flow velocities in
MCA in normal
conditions and after
1000 mg
acetazolamide i.v.
Non-significantly better CVRC
in AD than VD
(Continued)
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Table 3 | Continued
Reference Aim of study Type of study n MCI n AD n VD N Controls Parameters Outcome
Matteis et al.
(1998)
Comparison of
CVRC in AD and
VD
Cross-sectional 10 10 20 Flow velocities in
MCA during apnea,
hand movement and
verbal and design
discrimination
CVRC to apnea lower in VD;
hand
movement – contralateral
increase in flow in AD and
controls, bilateral in VD;
bilateral response on
cognitive stimuli in AD and
VD, corresponding side
response in controls
Provinciali
et al. (1990)
Comparison of
CVRC in AD, VD
and controls
Cross-sectional 20 20 25 Flow velocities in
MCA at rest, after
hyperventilation,
apnea and 5 min air
rebreathing
Higher PI, lower velocity
decrease in hyperventilation
in both dementias; rest flow
velocities and response to
hypercapnia lower in VD than
AD or controls
Ries et al.
(1993)
Utility of TCD in
differentiation of
AD and
multi-infarct
dementia
Cross-sectional 24 17 64 PSV and EDV in all
large intracranial
vessels bilaterally,
pulse curve in MCA
No difference in PSV in all
three groups, difference in
MFV, EDV and effective
pulsatility range in VD
compared to AD or controls
Roher et al.
(2006)
Comparison of
mean flow
velocities and PI
in intracranial
arteries in AD and
controls
Cross-sectional 25 30 Flow velocities in 16
different segments
of circle of Willis
Higher PIs in AD,
non-significantly lower mean
flow velocities in AD
Roher et al.
(2011)
Utility of TCD in
diagnosing and
preventing AD
Cross-sectional 11 42 50 Flow velocities in 16
different segments
of circle of Willis
Significant difference in MFV
and PI in left siphon, left ICA
and right distal MCA between
AD and controls
Rosengarten
et al. (2006)
Influence of
ACHEI treatment
on vasoregulation
in AD
Longitudinal 8 16 Flow velocities in
PCA and MCA in rest
and at stimulation
(text reading) at
baseline, after
4 weeks of donepezil
5 mg and after
another 4 weeks of
donepezil 10 mg
Decrease in attenuation
parameter after 10 mg in
AD=dose dependent
resolution of functional
vascular deficit
Rosengarten
et al. (2007)
Comparison of
activation-flow
coupling in AD,
VD and controls
Cross-sectional 15 10 15 Flow velocities in
PCA and MCA in rest
and at stimulation
(text reading)
Lower increase in PSV in VD
Ruitenberg
et al. (2005)
Correlation of
flow velocities
with cognitive
decline and
hippocampal
atrophy
Cross-sectional 13 1 1718 Flow velocities in
MCAs at rest and
after 5 min of 5%
CO2
Greater PSV, MFV, EDV – less
likely dementia and bigger
hippocampus and amygdala
No association of CVRC and
presence of dementia
(Continued)
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Table 3 | Continued
Reference Aim of study Type of study n MCI n AD n VD N Controls Parameters Outcome
Silvestrini et al.
(2006)
Influence of
cerebral
hemodynamics
alterations on the
evolution of
cognitive
impairment
Longitudinal 53 Flow velocities in
MCAs at rest and
after breath-holding,
time 0 and
12 month, during this
time donepezil 5 mg
daily for 3 month,
then 10 mg daily
Positive correlation of
neuropsychological tests
changes with BHI, age and
DM
Silvestrini et al.
(2009), Stefani
et al. (2009)
Comparison of
cerebral
hemodynamics in
AD and controls
Cross-sectional 40 40 Flow velocities, PI
and BHI in MCA
Lower MFV, higher PI and
lower BHI in MCA in AD than
in controls
Sun et al.
(2007)
Changes in
cerebral flow
velocities in MCI
and controls
Cross-sectional 30 30 Flow velocities in
MCA, ACA, BA
Decreased PSV, MFV and
EDV in MCA and ACA in MCI
compared to controls
Vicenzini et al.
(2007)
Comparison of
flow velocities, PI
and CVRC in AD,
VD, and controls
Cross-sectional 60 58 62 Flow velocities in
MCA in normal
conditions, after
hyperventilation and
CO2 inhalation
Lower MFV, higher PI and
lower CVRC in AD and VD
compared to controls
Viticchi et al.
(2012)
Association of
carotid
atherosclerosis
and
cerebrovascular
reserve capacity
with the risk of
conversion from
MCI to AD
Longitudinal 117 21 IMT and plaques in
CCA, BHI in MCAs
Association of higher IMT and
lower BHI with faster
progression from MCI to
dementia
ACA, anterior cerebral artery; ACHEI, acetylcholine esterase inhibitor; AD, Alzheimer’s disease; BA, basilar artery; CAA, cerebral amyloid angiopathy; CVRC,
cerebrovascular reserve capacity; DM, diabetes mellitus; EDV, end diastolic velocity; ICA, internal carotid artery; MCA, middle cerebral artery; MCI, mild cognitive
impairment; MFV, mean flow velocity; PCA, posterior cerebral artery; PI, pulsatility index; PSV, peak systolic velocity; VD, vascular dementia.
(Silvestrini et al., 2006). MCI patients with pathological values of
BHI have greater risk of converting to dementia than patients with
normal values (Viticchi et al., 2012). Details of ultrasound projects
focused on flow velocities and cerebrovascular reserve capacity in
AD are listed in Table 3.
SPONTANEOUS CEREBRAL MICROEMBOLIZATION AND PARADOXICAL
EMBOLIZATION VIA RIGHT–LEFT SHUNTS
Recent evidence suggests that cerebral microemboli can lead to a
cognitive decline (Pugsley et al., 1994; Gaudet et al., 2009). Cere-
bral microemboli can originate from arterial sources or venous
sources in setting of right–left shunts (intracardiac – foramen ovale
patens, atrial septal defects). The spontaneous cerebral emboliza-
tion can be monitored using a headframe with attached ultra-
sound probes for time periods of usually 1–24 h. Right–left shunts
are examined by intravenous injection of a microbubble agent
(agitated saline or hydroxyethyl starch) and observing the presence
of microbubbles in brain vessels using transcranial ultrasound at
rest and during the Valsalva maneuver. The accuracy of right–left
shunt assessment by transcranial Doppler ultrasound compared to
the transesophageal echocardiography as a gold standard ranges
from 68 to 100% according to the reports in literature, some
of them claiming the transcranial Doppler method even more
accurate (Nemec et al., 1991; Teague and Sharma, 1991; Di Tullio
et al., 1993; Jauss et al., 1994; Job et al., 1994; Sastry et al., 2009). The
sensitivity and reproducibility of the examination is highest when
performed repeatedly (twice) with the use of Valsalva maneuver
(Droste et al., 1999).
There were not many studies focused on spontaneous cere-
bral embolization in AD. One work suggested that it is more
frequent in patients with AD or VD than in healthy controls
(Purandare et al., 2005). This suggestion was later confirmed
by a larger case–control study (Purandare et al., 2006). In this
particular project, there was no significant difference in the
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Table 4 | Spontaneous cerebral microembolization and paradoxical embolization via right–left shunts.
Reference Aim of study Type of study n MCI n AD n VD n Controls Parameters Outcome
Purandare
et al. (2005)
Spontaneous cerebral
microemboli, v-a
circulation shunts and
carotid artery disease in
dementia and controls
Cross-sectional 24 17 16 Spontaneus
cerebral emboli in
MCAs, bubbles in
MCAs, PSV in ICA
More cerebral microemboli
in VD than controls, in AD
not significant, no
difference in shunt or
carotid stenosis between
dementia and controls
Purandare
et al. (2006)
Spontaneous cerebral
microemboli, v-a
circulation shunts and
carotid artery disease in
dementia and controls
Cross-sectional 85 85 150 Spontaneus
cerebral emboli in
MCAs, bubbles in
MCAs, PSV in ICA
More cerebral microemboli
in VD and AD than controls,
no difference in shunt or
carotid stenosis between
dementia and controls
Purandare and
Burns (2009)
Association of
spontaneous cerebral
microembolization with
dementia etiology,
dementia progression
and depression in
dementia or controls
Cross-sectional
Longitudinal
85 85 150 Spontaneus
cerebral emboli in
MCAs, bubbles in
MCAs, PSV in ICA.
Neuropsychological
tests in time 0 and
6 months
More cerebral microemboli
in AD and VD than
controls, more in
depression (both dementia
and controls). Association
with more rapid cognitive
decline in dementia
AD, Alzheimer’s disease; ICA, internal carotid artery; MCA, middle cerebral artery; MCI, mild cognitive impairment; PSV, peak systolic velocity; v-a, venous-to-arterial;
VD, vascular dementia.
Table 5 | Neurosonological parameters in AD – summary.
Ultrasound parameter Findings in AD Conclusion
IMT Increased IMT associated with increased short-term risk of
developing AD, converting from MCI to AD, and lower response to
galantamine treatment of AD
In combination with other neurosonological methods
and vascular risks assessment can help to identify
patients in higher risk of faster progression of AD
Correlates with the progression of AD
Carotid
atherosclerosis
Higher degree of carotid atherosclerosis associated with increased
short-term risk of developing AD and converting from MCI to AD
In combination with other neurosonological methods
and vascular risks assessment can help to identify
patients in higher risk of faster progression of ADCorrelates with the progression of AD
Total cerebral blood
flow
Decreased in AD Inconclusive
Not dependent on brain atrophy
Longitudinal data not available
Flow velocities Variably decreased MFV in MCA in AD Inconclusive
Decreased flow velocities associated with increased risk of
developing AD
Cerebrovascular
reserve capacity
Decreased in AD Best correlation with AD incidence and progression
among all neurosonological parametersDecreased CVRC associated with increased risk of developing AD
AD, Alzheimer’s disease; IMT, intima-media thickness; MCA, middle cerebral artery; MCI, mild cognitive impairment; MFV, mean flow velocity.
incidence of carotid artery atherosclerosis – i.e., possible source
of microembolization. Prevalence of patent foramen ovale in AD
and VD cohort was 33% in this study, which is higher than usu-
ally reported 20–25% in general population (Hara et al., 2005),
but no larger epidemiological studies of prevalence in AD were
done. The same author found the association of spontaneous
cerebral microembolization with more rapid cognitive decline
in dementia (Purandare and Burns, 2009). Details of ultrasound
projects focused on spontaneous and paradoxical embolization in
AD are listed in Table 4.
CONCLUSION
The current evidence suggests that the brain perfusion in
AD patients, in general, is impaired compared to healthy
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non-demented population. The most prominent ultrasonograph-
ical findings in extracranial circulation in AD patients show an
increased IMT and higher burden of carotid artery atherosclero-
sis. The most often identified changes in intracranial circulation
are lower flow velocities, lower total CBF (not explained by brain
atrophy only), and most notably impaired cerebrovascular reserve
capacity (Table 5). These findings seem to be valid for both AD
and VD.
Ultrasonography of extra- and intracranial brain vessels can be
helpful in AD patients to identify individuals who are in a higher
risk of disease progression. Ultrasonography can be also useful
for stratification of MCI patients and can contribute to predict the
risk of conversion to AD. The vascular risk factors surveillance and
treatment in preclinical stages of AD is of great clinical importance
and it could help to delay the development of cognitive decline in
susceptible individuals. Ultrasonography is not especially benefi-
cial in differentiating AD and VD, because the microvasculature is
altered in both types of dementia.
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